Skip to main content

. 1991 May;84(5):306. doi: 10.1177/014107689108400519

Dermatomyositis treated with cyclosporin.

G M Kavanagh ¹, J S Ross ¹, M M Black ¹

PMCID: PMC1293233 PMID: 2041011

306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Colombani P. M., Hess A. D. T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action. Biochem Pharmacol. 1987 Nov 15;36(22):3789–3793. doi: 10.1016/0006-2952(87)90438-2. [DOI] [PubMed] [Google Scholar]
Dawkins R. L., Mastaglia F. L. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med. 1973 Mar 1;288(9):434–438. doi: 10.1056/NEJM197303012880903. [DOI] [PubMed] [Google Scholar]
Heckmatt J., Hasson N., Saunders C., Thompson N., Peters A. M., Cambridge G., Rose M., Hyde S. A., Dubowitz V. Cyclosporin in juvenile dermatomyositis. Lancet. 1989 May 13;1(8646):1063–1066. doi: 10.1016/s0140-6736(89)92456-2. [DOI] [PubMed] [Google Scholar]
Penn I. Cyclosporine and oncogenesis. Mt Sinai J Med. 1987 Sep;54(6):460–464. [PubMed] [Google Scholar]
Plotz P. H., Dalakas M., Leff R. L., Love L. A., Miller F. W., Cronin M. E. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med. 1989 Jul 15;111(2):143–157. doi: 10.7326/0003-4819-111-2-143. [DOI] [PubMed] [Google Scholar]
van der Meer S., Imhof J. W., Borleffs J. C. Cyclosporin for polymyositis. Ann Rheum Dis. 1986 Jul;45(7):612–612. doi: 10.1136/ard.45.7.612-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES